MCAC Proposes Up-Front Decision Modeling For CMS Coverage Reviews
This article was originally published in The Gray Sheet
Executive Summary
CMS and manufacturers should develop prospective decision models to guide new technology through the Medicare review process, the Medicare Coverage Advisory Committee Executive Committee recommends
You may also be interested in...
Alzheimer’s PET Coverage Decision Stalls At HHS; Limited Indication Ahead?
HHS Secretary Tommy Thompson will convene an expert panel to help CMS define the patient population for which PET imaging is an appropriate test for Alzheimer's disease, according to Senate staffers
Alzheimer’s PET Coverage Decision Stalls At HHS; Limited Indication Ahead?
HHS Secretary Tommy Thompson will convene an expert panel to help CMS define the patient population for which PET imaging is an appropriate test for Alzheimer's disease, according to Senate staffers
PET Faces A No-Win Situation At MCAC Review Of Alzheimer’s Treatment
The Medicare Coverage Advisory Committee Diagnostic Imaging Panel's rejection of PET imaging for use in treating Alzheimer's disease demonstrates that diagnostic coverage reviews in the future may depend as much on the treatment in question as the diagnostic itself